Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
24.20
+1.51 (6.65%)
At close: Oct 8, 2025, 4:00 PM EDT
24.35
+0.15 (0.62%)
After-hours: Oct 8, 2025, 7:55 PM EDT

Janux Therapeutics Statistics

Total Valuation

JANX has a market cap or net worth of $1.45 billion. The enterprise value is $480.45 million.

Market Cap1.45B
Enterprise Value 480.45M

Important Dates

The next estimated earnings date is Wednesday, November 5, 2025, after market close.

Earnings Date Nov 5, 2025
Ex-Dividend Date n/a

Share Statistics

JANX has 60.09 million shares outstanding. The number of shares has increased by 20.02% in one year.

Current Share Class 60.09M
Shares Outstanding 60.09M
Shares Change (YoY) +20.02%
Shares Change (QoQ) +0.18%
Owned by Insiders (%) 6.55%
Owned by Institutions (%) 91.60%
Float 44.97M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3,312.70
Forward PS 417.61
PB Ratio 1.45
P/TBV Ratio 1.47
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1,094.42
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 47.03, with a Debt / Equity ratio of 0.02.

Current Ratio 47.03
Quick Ratio 46.85
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -12.82% and return on invested capital (ROIC) is -10.69%.

Return on Equity (ROE) -12.82%
Return on Assets (ROA) -10.51%
Return on Invested Capital (ROIC) -10.69%
Return on Capital Employed (ROCE) -14.33%
Revenue Per Employee $5,420
Profits Per Employee -$1.30M
Employee Count81
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -45.19% in the last 52 weeks. The beta is 2.82, so JANX's price volatility has been higher than the market average.

Beta (5Y) 2.82
52-Week Price Change -45.19%
50-Day Moving Average 23.79
200-Day Moving Average 30.18
Relative Strength Index (RSI) 53.36
Average Volume (20 Days) 790,806

Short Selling Information

The latest short interest is 8.30 million, so 13.81% of the outstanding shares have been sold short.

Short Interest 8.30M
Short Previous Month 8.05M
Short % of Shares Out 13.81%
Short % of Float 18.46%
Short Ratio (days to cover) 13.08

Income Statement

In the last 12 months, JANX had revenue of $439,000 and -$105.64 million in losses. Loss per share was -$1.80.

Revenue439,000
Gross Profit -67.95M
Operating Income -144.88M
Pretax Income -105.64M
Net Income -105.64M
EBITDA -142.80M
EBIT -144.88M
Loss Per Share -$1.80
Full Income Statement

Balance Sheet

The company has $996.01 million in cash and $22.19 million in debt, giving a net cash position of $973.82 million or $16.20 per share.

Cash & Cash Equivalents 996.01M
Total Debt 22.19M
Net Cash 973.82M
Net Cash Per Share $16.20
Equity (Book Value) 990.52M
Book Value Per Share 16.70
Working Capital 984.17M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$59.79 million and capital expenditures -$911,000, giving a free cash flow of -$60.70 million.

Operating Cash Flow -59.79M
Capital Expenditures -911,000
Free Cash Flow -60.70M
FCF Per Share -$1.01
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -33,002.05%
Pretax Margin -24,064.01%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

JANX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -20.02%
Shareholder Yield -20.02%
Earnings Yield -7.26%
FCF Yield -4.17%

Analyst Forecast

The average price target for JANX is $76.55, which is 216.32% higher than the current price. The consensus rating is "Strong Buy".

Price Target $76.55
Price Target Difference 216.32%
Analyst Consensus Strong Buy
Analyst Count 11
Revenue Growth Forecast (5Y) 79.90%
EPS Growth Forecast (5Y) 17.27%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

JANX has an Altman Z-Score of 32.26 and a Piotroski F-Score of 1.

Altman Z-Score 32.26
Piotroski F-Score 1